查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2004251

痔疮治疗器材市场：2026-2032年全球市场预测（依产品类型、最终用户、分销管道及支付方划分）

Hemorrhoid Treatment Devices Market by Product Type, End User, Distribution Channel, Payer Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，痔疮治疗器材市场价值将达到 8.4712 亿美元，到 2026 年将成长至 8.9967 亿美元，到 2032 年将达到 12.7526 亿美元，复合年增长率为 6.01%。

主要市场统计数据
基准年 2025 8.4712亿美元
预计年份：2026年 8.9967亿美元
预测年份 2032 1,275,260,000 美元
复合年增长率 (%) 6.01%

这篇简明的临床和商业性介绍概述了医疗设备的多样化、医疗保健服务环境的变化以及患者的期望如何重塑痔疮治疗方法。

痔疮治疗器材融合了临床需求、技术主导和不断发展的医疗服务模式。近年来，临床医生越来越重视微创治疗方案，以缩短恢復时间并实现门诊治疗。医疗设备开发商也积极回应，推出了多种治疗平台，包括冷冻疗法、雷射疗法、红外线凝固疗法、橡皮筋结扎术和硬化疗法。这种多样化既体现了医疗设备工程技术的进步，也反映了治疗过程中对病人耐受性、满意度和成本控制的日益重视。

临床预期、监管澄清、供应链韧性以及数位支援工具的融合如何推动痔疮治疗设备进入创新新时代。

在临床医生、保险公司和患者日益增长的压力下，痔疮治疗医疗设备领域发生了翻天覆地的变化。科技进步使微创手术更加稳定普及。这体现在从能量供应系统和器械的人体工学改进到更优质耗材的设计等各个方面。因此，曾经仅限于医院手术室使用的医疗设备正越来越多地被引入门诊手术中心和诊所，从而加快手术流程并降低单次手术成本。

2025 年的关税调整迫使製造商和买家重组其供应链，将优先事项转向国内采购，并在整个生态系统中重新谈判筹资策略。

美国2025年实施的关税措施对痔疮治疗器械的整个生态系统产生了重大且多方面的影响。对于依赖进口零件的製造商而言，例如雷射系统的高精度光学元件、冷冻疗法的专用压缩机和气体，以及橡皮筋结扎术的专用一次性分配器，新增关税增加了进口成本，并促使他们迅速重新评估筹资策略。为此，许多供应商加快了供应商多元化，寻求透过替代关税分类来降低关税，并积极寻求本地生产伙伴关係关係，以缓解利润率下降的影响。

综合細項分析将产品、最终用户、分销和支付方细分连结起来，以揭示临床、物流和商业性影响。

产品细分揭示了多种治疗方法和器械结构，每种方法和结构都有其独特的临床和商业性意义。根据产品类型，市场可分为以下几类并进行研究：冷冻治疗器械、痔切除器械、红外线凝固器械、雷射治疗器械、橡皮筋结扎器械和硬化治疗器械。在冷冻治疗中，气体压缩系统和液态氮平台之间的差异会影响物流、耗材需求以及在临床实践中的适用性。痔疮切除器械的类型包括Ligasure器械、吻合器器械和传统手术刀，手术复杂程度、手术时间和术后效果的差异会影响医院和外科医师的选择。红外线凝固器械分为接触式和非接触式，雷射治疗器械包括二氧化碳雷射器械、二极体雷射器械和Nd:YAG雷射器械。每种器械的组织互动特性和资本投入规模都不同。橡皮筋结扎装置种类繁多，从一次性使用到多环、可重复使用以及单频段装置，每种装置都会对特定病例的经济效益和感染控制流程产生影响。硬化疗法装置则根据其使用的注射器分为乙氧基硬化剂和聚多卡醇注射器，二者的区别决定了临床操作、浓度选择和监管方面的考虑。

美洲、欧洲、中东和非洲以及亚太地区在监管、报销和製造趋势方面的差异如何影响技术采用和商业化？

区域趋势受法律规范、支付模式和临床实践模式的影响，从而在技术采纳、证据要求和商业策略方面形成不同的路径。在美洲，医院系统和门诊手术中心正在推动微创平台的早期应用，因为其显着的成本优势与组织效率目标相符。与大规模集团采购组织和综合医疗网络的密切关係也影响着合约和价格谈判。

临床倡议、模组化创新、策略伙伴关係和综合服务模式所驱动的竞争动态，正在决定差异化和市场吸引力。

在竞争激烈的市场环境中，老牌供应商面临敏捷型新兴企业的挑战，后者着重于利基创新、耗材经济和服务模式。主要企业投入大量资金进行临床证据收集和使用者培训，以降低市场接受度，而新兴企业则专注于模组化设备、一次性耗材，并利用数位技术实现产品差异化。策略伙伴关係、共同开发契约和选择性授权协议已成为拓展产品系列的常用手段，无需承担垂直整合带来的巨额资本负担。

为製造商和相关人员提供切实可行的策略建议，以协调产品设计、证据产生、分销和供应链韧性，从而实现可持续的市场成功。

产业领导企业应优先考虑多管齐下的策略，将产品设计、证据产生和商业性执行有机结合，以确保可持续的竞争优势。首先，产品开发应着重于降低手术复杂性和耗材用量，同时维持或改善临床疗效，使产品能够广泛应用于包括门诊和诊所在内的各种医疗环境中。同时，他们必须投资于可操作的临床研究和真实世界数据（REW），以证明产品能够缩短恢復时间、减少併发症并降低后续医疗资源的利用率，从而赢得支付方和采购委员会的认可。

我们采用透明的混合方法研究途径，结合专家访谈、二手检验整合和三角验证，提供可重复的策略见解。

本报告的研究透过结合一手质性访谈、整合二手资料和严谨的检验，确保了其可靠性和情境相关性。一手研究包括对临床专业人员、采购经理、门诊中心管理人员和医疗设备公司高阶主管进行结构化访谈，以了解目前的实务模式、采购重点和创新蓝图。基于这些访谈，研究人员进行了主题编码，以识别临床驱动因素、推广障碍和未满足的需求。

策略结论强调，实证创新、高度适应性的商业化和供应链敏捷性对于实现长期应用至关重要。

总之，痔疮治疗器材领域正经历着一场重大变革，其驱动力包括技术多样化、治疗部位偏好的改变以及对成本效益的日益增长的期望。随着临床医生和消费者寻求能够缩短恢復期并减少后续资源消耗的治疗方法，微创治疗方法和高耗材效率的器械正受到越来越多的关注。同时，供应链趋势和关税政策的变化也凸显了生产柔软性和精细化定价策略的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 痔疮治疗器材市场：依产品类型划分

  • 冷冻疗法设备
    • 气体压缩型
    • 液态氮型
  • 痔疮切除器械
    • Ligasure 器械
    • 订书机
    • 传统手术器械
  • 红外线凝血装置
    • 接触式红外线凝固
    • 非接触式红外线凝固
  • 雷射治疗设备
    • 二氧化碳雷射设备
    • 二极体雷射设备
    • Nd:YAG雷射设备
  • 橡皮筋结扎装置
  • 硬化疗法设备
    • 乙氧硬化剂注射器
    • 聚多卡醇注射器

第九章 痔疮治疗器材市场：依最终用户划分

  • 门诊手术中心
    • 医院所属的门诊手术中心
    • 由医师拥有的门诊手术中心
  • 诊所
    • 一般诊所
    • 直肠科诊所
  • 居家照护设施
    • 由护理师管理
    • 自我管理
  • 医院
    • 私立医院
    • 公立医院

第十章 痔疮治疗器材市场：依分销管道划分

  • 在线的
  • 离线

第十一章 依支付方类型分類的痔疮治疗器材市场

  • 公共保险
    • 医疗补助
    • 联邦医疗保险
  • 自费
    • 支援计划
    • 自费
  • 私人保险
    • 雇主出资的保险
    • 个人计划

第十二章 痔疮治疗设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 痔疮治疗器材市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 痔疮治疗器材市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国痔疮治疗器材市场

第十六章 中国痔疮治疗设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AMI Agency for Medical Innovations GmbH
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • BOWA-electronic GmbH & Co. KG
  • CONMED Corporation
  • Cook Medical
  • Erbe Elektromedizin GmbH
  • Hologic Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson
  • Karl Storz SE & Co. KG
  • Medline Industries LP
  • Medtronic plc
  • Mermaid Medical A/S
  • Neomedic Limited
  • OBP Surgical Corporation
  • Olympus Corporation
  • Privi Medical
  • Purple Surgical
  • Renew Medical Inc.
  • Richard Wolf GmbH
  • Sklar Surgical Instruments
  • Smith & Nephew plc
  • Surkon Medical Co., Ltd.
  • Teleflex Incorporated
Product Code: MRR-450A0628DDAC

The Hemorrhoid Treatment Devices Market was valued at USD 847.12 million in 2025 and is projected to grow to USD 899.67 million in 2026, with a CAGR of 6.01%, reaching USD 1,275.26 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 847.12 million
Estimated Year [2026] USD 899.67 million
Forecast Year [2032] USD 1,275.26 million
CAGR (%) 6.01%

A concise clinical and commercial introduction framing how device diversity, care setting shifts, and patient expectations are reshaping hemorrhoid treatment approaches

Hemorrhoid treatment devices occupy an intersection of clinical necessity, technology-driven innovation and shifting care delivery models. Over recent years, clinicians have increasingly prioritized minimally invasive options that reduce recovery time and enable outpatient management, while device developers have responded with diversified platforms spanning cryotherapy, laser, infrared coagulation, rubber band ligation and sclerotherapy. This diversification reflects both advances in device engineering and a broader emphasis on procedure tolerability, patient satisfaction and cost containment within care pathways.

Clinical practice patterns are evolving in parallel with patient expectations. Where traditional excisional techniques once dominated, there is growing adoption of less invasive modalities that can be performed in ambulatory surgical centers, clinics or even home care settings under defined protocols. At the same time, payer scrutiny and hospital procurement dynamics drive demand for robust clinical evidence and straightforward cost-of-care narratives, encouraging vendors to prioritize outcomes data, streamlined training programs and consumable cost control.

Consequently, stakeholders across the value chain are recalibrating strategy: clinicians refine treatment algorithms, hospitals and ambulatory centers evaluate capital versus disposable economics, and device manufacturers accelerate product refinement and post-market evidence generation. This report introduction sets the stage for a deeper analysis of the clinical drivers, technology pathways and commercial implications shaping the hemorrhoid treatment devices landscape.

How converging clinical expectations, regulatory clarity, supply chain resilience, and digital support tools are catalyzing a new era of hemorrhoid device innovation

The landscape for hemorrhoid treatment devices has undergone transformative shifts driven by converging pressures from clinicians, payers and patients. Technological refinement has made minimally invasive procedures more consistent and accessible, rising from improvements in energy delivery systems and instrument ergonomics to better consumable design. As a result, devices once confined to hospital operating rooms increasingly migrate to ambulatory surgical centers and outpatient clinics, enabling faster throughput and lower per-procedure costs.

Regulatory and reimbursement evolutions further accelerate change. Regulators have clarified pathways for incremental device enhancements, while payers have signaled preferences for procedures with demonstrable reductions in downstream resource use. This has encouraged manufacturers to invest in post-market studies and value-based evidence that substantiate shorter recovery periods and reduced complication rates. In parallel, the training paradigm has shifted toward modular curricula, virtual simulation and proctology-focused upskilling that shorten adoption curves for new technologies.

Supply chain resilience and component sourcing also represent a pivotal shift. Manufacturers are diversifying suppliers and exploring regional manufacturing to mitigate geopolitical risk and tariff exposure. Concurrently, digital tools such as remote monitoring, teleconsultation and patient engagement platforms are beginning to play a supporting role in pre-procedure assessment and post-procedure follow-up, redefining the perioperative experience for both patients and clinicians.

The 2025 tariff adjustments compelled manufacturers and purchasers to restructure supply chains, reprioritize domestic sourcing, and renegotiate procurement strategies across the ecosystem

The introduction of United States tariff measures in 2025 produced a notable, multifaceted impact across the hemorrhoid treatment device ecosystem. For manufacturers that rely on imported components-high-precision optics for laser systems, specialized compressors and gases for cryotherapy, and proprietary disposable dispensers for rubber band ligation-the additional duties increased landed costs and prompted rapid reassessment of sourcing strategies. In response, many suppliers accelerated supplier diversification, sought tariff mitigation through alternate tariff classifications and pursued localized production partnerships to contain margin erosion.

These cost pressures cascaded through distribution channels. Hospital procurement teams intensified negotiations on consumable pricing and service contracts, while some ambulatory centers shifted preference toward devices with lower consumable intensity or with domestic supply footprints. Payers and purchasing coalitions responded by scrutinizing device line-item costs more closely, which in turn influenced product positioning and promotional strategies. Importantly, the tariff environment also adjusted timelines for product launches and upgrades as manufacturers prioritized products with favorable supply chain visibility.

Innovation agendas and go-to-market plans adapted accordingly. Firms with robust in-region manufacturing or assembly capabilities gained advantage in speed-to-market and pricing stability, while smaller manufacturers explored contract manufacturing and licensing to preserve market access. Overall, the tariff developments highlighted the strategic importance of supply chain agility, cost modeling sophistication and proactive engagement with procurement stakeholders across hospitals, clinics and distribution partners.

An integrated segmentation analysis that connects product, end user, distribution and payer distinctions to reveal clinical, logistical, and commercial implications

Product segmentation reveals a broad array of therapeutic approaches and device architectures, with each pathway presenting distinct clinical and commercial implications. Based on Product Type, the market is studied across Cryotherapy Devices, Hemorrhoidectomy Devices, Infrared Coagulation Devices, Laser Treatment Devices, Rubber Band Ligation Devices, and Sclerotherapy Devices. Within cryotherapy, the distinction between gas compression based systems and liquid nitrogen based platforms affects logistics, consumable requirements and site-of-care suitability. Hemorrhoidectomy device variety spans Ligasure devices, stapler devices and traditional scalpel instruments, where differences in procedural complexity, operative time and postoperative outcomes inform hospital and surgeon preferences. Infrared coagulation devices split into contact and non-contact modalities, and laser treatment options include CO2 laser devices, diode laser devices and Nd:YAG laser devices, each offering divergent tissue interaction profiles and capital intensity. Rubber band ligation devices range from disposable dispensers to multi-band, reusable and single-band dispensers, which influence per-case economics and infection control workflows. Sclerotherapy devices are differentiated by Aethoxysklerol syringes and Polidocanol syringes, a distinction that shapes clinical handling, concentration selection and regulatory considerations.

End user segmentation underscores where adoption pressure and investment will concentrate. Based on End User, the market is studied across Ambulatory Surgical Centers, Clinics, Home Care Settings, and Hospitals. Ambulatory surgical centers further bifurcate into hospital-owned and physician-owned entities, each with differing capital approval processes and throughput incentives. Clinics are profiled as general clinics and proctology clinics, where specialized expertise and referral patterns alter procedural mix. Home care settings include nurse-administration and self-administration scenarios, highlighting the growing interest in patient-centric, low-complexity interventions. Hospitals, both private and public, remain focal points for high-acuity cases and for early adoption of capital-intensive platforms.

Distribution and payer segmentation illuminate access and reimbursement dynamics. Based on Distribution Channel, the market is studied across direct sales, hospital purchase, online pharmacies and retail pharmacies, which determine how devices and consumables reach clinicians and patients. Based on Payer Type, the market is studied across government insurance, out-of-pocket and private insurance. Government insurance further segments into Medicaid and Medicare, while out-of-pocket splits into assistance programs and self-pay; private insurance is analyzed in terms of employer-funded plans and individual plans. Together, these segmentation layers frame where clinical adoption, pricing sensitivity and reimbursement engagement will shape commercial success.

How distinct regional regulatory, reimbursement, and manufacturing dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific influence adoption and commercialization

Regional dynamics create differentiated pathways for technology adoption, evidence requirements and commercial strategy, shaped by regulatory frameworks, payer models and clinical practice patterns. In the Americas, hospital systems and ambulatory surgical centers drive early adoption of minimally invasive platforms where demonstrable cost-of-care advantages align with institutional efficiency goals; close relationships with large group purchasing organizations and integrated delivery networks influence contracting and pricing negotiations.

Across Europe, Middle East & Africa, regulatory harmonization in certain markets coexists with fragmented reimbursement landscapes, prompting manufacturers to pursue targeted clinical evidence and country-specific value dossiers. In some EMEA markets, national procurement programs and centralized tendering favor cost-competitive consumable models, while in other jurisdictions private hospitals and specialized clinics accelerate uptake of premium energy-based devices.

In Asia-Pacific, a heterogeneous mix of mature and rapidly developing healthcare systems creates simultaneous opportunities for high-volume adoption and for innovative distribution partnerships. Manufacturing capacity and regional supply chains in this region support both export-oriented production and local assembly, which can reduce tariff exposure and improve responsiveness to demand volatility. Transitional phrases: collectively, these regional characteristics mean that go-to-market strategies must be tailored to local reimbursement conventions, procurement mechanisms, and the pace of clinical guideline adoption.

Competitive dynamics driven by clinical advocacy, modular innovation, strategic partnerships, and integrated service models that determine differentiation and market traction

The competitive landscape balances entrenched suppliers with agile challengers that emphasize niche innovation, consumable economics and service models. Leading companies invest heavily in clinical evidence generation and user training to lower barriers to adoption, while emerging firms concentrate on modular devices, single-use consumables and digital augmentation to differentiate their offerings. Strategic partnerships, co-development agreements and selective licensing deals are common pathways for extending portfolios without the full capital burden of vertical integration.

Companies that excel combine strong clinical advocacy with flexible commercial models, offering trial programs, bundled consumable pricing and integrated maintenance services. They also prioritize after-sales support and localized training to shorten learning curves for surgeons and clinic staff. In addition, robust supply chain networks and regional assembly facilities provide competitive advantages in markets affected by tariff shifts or logistics constraints.

Finally, M&A activity and targeted investments in adjacent technologies-such as energy delivery modules, disposable applicators and telehealth-enabled follow-up solutions-signal an appetite to broaden clinical utility and capture more of the peri-procedural value chain. These strategic moves reflect a market where differentiation increasingly rests on integrated solutions that connect device performance, clinical outcomes and total cost of care.

Practical strategic recommendations for manufacturers and stakeholders to align product design, evidence generation, distribution, and supply chain resilience for sustained market success

Industry leaders should prioritize a multi-faceted strategy that aligns product design, evidence generation and commercial execution to secure durable competitive advantage. First, focus product development on reducing procedural complexity and consumable intensity while preserving or improving clinical outcomes, enabling broader adoption across ambulatory and clinic settings. Simultaneously, invest in pragmatic clinical studies and real-world evidence that demonstrate shorter recovery times, fewer complications and lower downstream utilization to satisfy payers and procurement committees.

Second, redesign distribution and pricing models to reflect site-of-care economics. Offer flexible contracting, consumable bundles and pilot programs that lower adoption friction for ambulatory surgical centers, physician-owned facilities and clinics. Engage early with hospital procurement groups to align on total cost of ownership and to negotiate service-level agreements that include training and maintenance.

Third, shore up supply chain resilience by diversifying component suppliers, pursuing regional assembly and exploring creative tariff mitigation tactics. Fourth, build scalable training and digital support programs-virtual simulation, procedure libraries and tele-mentoring-that accelerate clinician proficiency and foster product loyalty. Lastly, pursue partnerships that expand clinical indications or integrate complementary technologies, and maintain active dialogue with regulators and payers to shape favorable adoption pathways and reimbursement recognition.

A transparent mixed-methods research approach combining expert interviews, secondary evidence synthesis, and triangulation to deliver reproducible strategic insights

The research underpinning this report combines primary qualitative interviews, secondary data synthesis and rigorous triangulation to ensure reliability and contextual relevance. Primary research included structured interviews with clinical specialists, procurement leaders, ambulatory center administrators and device executives to capture current practice patterns, purchasing priorities and innovation roadmaps. These interviews informed thematic coding that highlighted clinical drivers, adoption barriers and service unmet needs.

Secondary research consolidated peer-reviewed clinical literature, public regulatory filings, product manuals and company disclosures to validate technical claims and to map device feature sets. The analysis employed cross-validation techniques to reconcile differing source perspectives and to identify consistent signals across geographies and end-user types. In addition, subject matter experts reviewed draft findings to detect factual gaps and to confirm practical implications for commercialization and clinical adoption.

Limitations are acknowledged where primary access is constrained, such as in proprietary contract terms and in rapidly evolving tariff frameworks. To mitigate these constraints, sensitivity checks and scenario-based assessments were applied. The methodology emphasizes transparency, reproducibility and a clear link between evidence sources and analytical conclusions to support confident strategic decision making.

A strategic conclusion emphasizing the necessity of evidence-driven innovation, adaptable commercialization, and supply chain agility to capture long-term adoption

In conclusion, the hemorrhoid treatment device arena is undergoing a substantive reorientation driven by technology diversification, shifting site-of-care preferences and strengthened expectations for cost-effective outcomes. Minimally invasive modalities and consumable-efficient devices are gaining traction as clinicians and purchasers seek interventions that reduce recovery time and downstream resource use. Concurrently, supply chain dynamics and tariff developments underscore the need for manufacturing flexibility and nuanced pricing strategies.

Manufacturers that align product innovation with robust clinical evidence, adaptable commercial models and resilient sourcing will be best positioned to capture durable adoption across hospitals, ambulatory surgical centers, clinics and home care settings. Strategic emphasis on clinician training, payer engagement and integrated service offerings will accelerate uptake and foster long-term partnerships. Ultimately, success will favor those organizations that combine clinical credibility with pragmatic operational execution to meet the evolving demands of providers and patients.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hemorrhoid Treatment Devices Market, by Product Type

  • 8.1. Cryotherapy Devices
    • 8.1.1. Gas Compression Based
    • 8.1.2. Liquid Nitrogen Based
  • 8.2. Hemorrhoidectomy Devices
    • 8.2.1. Ligasure Devices
    • 8.2.2. Stapler Devices
    • 8.2.3. Traditional Scalpel Instruments
  • 8.3. Infrared Coagulation Devices
    • 8.3.1. Contact Infrared Coagulation
    • 8.3.2. Non-Contact Infrared Coagulation
  • 8.4. Laser Treatment Devices
    • 8.4.1. CO2 Laser Devices
    • 8.4.2. Diode Laser Devices
    • 8.4.3. Nd:YAG Laser Devices
  • 8.5. Rubber Band Ligation Devices
  • 8.6. Sclerotherapy Devices
    • 8.6.1. Aethoxysklerol Syringes
    • 8.6.2. Polidocanol Syringes

9. Hemorrhoid Treatment Devices Market, by End User

  • 9.1. Ambulatory Surgical Centers
    • 9.1.1. Hospital-Owned ASC
    • 9.1.2. Physician-Owned ASC
  • 9.2. Clinics
    • 9.2.1. General Clinics
    • 9.2.2. Proctology Clinics
  • 9.3. Home Care Settings
    • 9.3.1. Nurse-Administration
    • 9.3.2. Self-Administration
  • 9.4. Hospitals
    • 9.4.1. Private Hospitals
    • 9.4.2. Public Hospitals

10. Hemorrhoid Treatment Devices Market, by Distribution Channel

  • 10.1. Online
  • 10.2. Offline

11. Hemorrhoid Treatment Devices Market, by Payer Type

  • 11.1. Government Insurance
    • 11.1.1. Medicaid
    • 11.1.2. Medicare
  • 11.2. Out-of-Pocket
    • 11.2.1. Assistance Programs
    • 11.2.2. Self-Pay
  • 11.3. Private Insurance
    • 11.3.1. Employer-Funded Plans
    • 11.3.2. Individual Plans

12. Hemorrhoid Treatment Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Hemorrhoid Treatment Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Hemorrhoid Treatment Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Hemorrhoid Treatment Devices Market

16. China Hemorrhoid Treatment Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. A.M.I. Agency for Medical Innovations GmbH
  • 17.6. B. Braun Melsungen AG
  • 17.7. Boston Scientific Corporation
  • 17.8. BOWA-electronic GmbH & Co. KG
  • 17.9. CONMED Corporation
  • 17.10. Cook Medical
  • 17.11. Erbe Elektromedizin GmbH
  • 17.12. Hologic Inc.
  • 17.13. Integra LifeSciences Corporation
  • 17.14. Johnson & Johnson
  • 17.15. Karl Storz SE & Co. KG
  • 17.16. Medline Industries LP
  • 17.17. Medtronic plc
  • 17.18. Mermaid Medical A/S
  • 17.19. Neomedic Limited
  • 17.20. OBP Surgical Corporation
  • 17.21. Olympus Corporation
  • 17.22. Privi Medical
  • 17.23. Purple Surgical
  • 17.24. Renew Medical Inc.
  • 17.25. Richard Wolf GmbH
  • 17.26. Sklar Surgical Instruments
  • 17.27. Smith & Nephew plc
  • 17.28. Surkon Medical Co., Ltd.
  • 17.29. Teleflex Incorporated

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GAS COMPRESSION BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIQUID NITROGEN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LIGASURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY STAPLER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY TRADITIONAL SCALPEL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CONTACT INFRARED COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NON-CONTACT INFRARED COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CO2 LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DIODE LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ND:YAG LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY RUBBER BAND LIGATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AETHOXYSKLEROL SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY POLIDOCANOL SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITAL-OWNED ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PHYSICIAN-OWNED ASC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GENERAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PROCTOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY NURSE-ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICAID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY MEDICARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ASSISTANCE PROGRAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ASSISTANCE PROGRAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY ASSISTANCE PROGRAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-PAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-PAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SELF-PAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY EMPLOYER-FUNDED PLANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY EMPLOYER-FUNDED PLANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY EMPLOYER-FUNDED PLANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INDIVIDUAL PLANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INDIVIDUAL PLANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INDIVIDUAL PLANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GOVERNMENT INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY OUT-OF-POCKET, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRIVATE INSURANCE, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CRYOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HEMORRHOIDECTOMY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY INFRARED COAGULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY LASER TREATMENT DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN HEMORRHOID TREATMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2